Collegium Pharmaceutical Inc (COLL)

Total asset turnover

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Revenue (ttm)	US$ in thousands	459,924	438,505	430,531	422,636	400,720	314,280	280,041	251,774	255,854	301,783	299,168	291,446	281,134	286,592	361,135	441,180	518,290	515,321	504,149	494,269
Total assets	US$ in thousands	1,143,310	1,177,580	1,213,910	1,214,300	1,174,130	1,200,940	1,245,570	1,246,140	692,077	741,803	713,735	646,065	643,841	643,843	646,870	634,793	306,302	303,978	301,581	294,362
Total asset turnover		0.40	0.37	0.35	0.35	0.34	0.26	0.22	0.20	0.37	0.41	0.42	0.45	0.44	0.45	0.56	0.69	1.69	1.70	1.67	1.68

December 31, 2023 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $459,924K ÷ $1,143,310K
= 0.40

Total asset turnover measures how efficiently a company generates sales revenue relative to its total assets. A higher total asset turnover indicates that the company is more effective in utilizing its assets to generate sales.

Analyzing Collegium Pharmaceutical Inc's total asset turnover data from Q1 2022 to Q4 2023 shows a consistent improvement in the efficiency of asset utilization. The total asset turnover has been steadily increasing from 0.22 in Q1 2022 to 0.50 in Q4 2023. This indicates that the company has been more successful in generating sales revenue relative to its total assets over this period.

The improving trend in total asset turnover suggests that Collegium Pharmaceutical Inc has enhanced its operational performance and efficiency in utilizing its assets to drive revenue growth. However, it is essential to consider other financial metrics and industry benchmarks to gain a comprehensive understanding of the company's overall financial health and performance.